银杏达莫注射液联合克林澳治疗急性脑梗塞随机平行对照研究

Yinxing Damo Injection Combine Kelinao Random Parallel Control Study the Treatment of Acute Cerebral Infarction

[目的]观察银杏达莫注射液联合克林澳治疗急性脑梗塞疗效。[方法]使用随机平行对照方法,将64例住院患者按随机数字表法分为两组。常规治疗,控制血压,降颅内压、血糖等。对照组克林澳,2mL+320mL,静滴。治疗组银杏达莫注射液,20mL+250mL,1次/d,静滴。克林澳治疗同对照组。连续治疗14d为1疗程。观测临床症状、不良反应。连续治疗2疗程,判定疗效。[结果]治疗组基本治愈20例,显著进步6例,好转4例,无效2例,总有效率93.75%。对照组基本治愈10例,显著进步5例,好转7例,无效10例,总有效率68.75%。治疗组疗效优于对照组(P<0.05)。[结论]银杏达莫注射液联合克林澳治疗急性脑梗塞效果显著,值得推广。

[Objective]observed Yinxingdamo Kelinao injection combined treatment of acute cerebral infarction.[Methods]Using randomized controlled method,64 cases of hospitalized patients were randomly divided into two groups randomly. General symptomatic and supportive treatment,such as controlling blood pressure,lowering intracranial pressure,blood sugar and other appropriate treatment. Control group Kelinao,2mL +320 ml,intravenous infusion. Treatment group Yinxingdamo injection,20mL +250 mL,1 times /d,intravenous infusion. Kelinao treatment with the control group.14d is a course of continuous treatment.Observation of clinical symptoms and adverse reactions. 2 courses of continuous treatment, to determine efficacy.[Results]treatment group were cured 20 cases,significant progress in six cases,improved in 4 cases,2 cases,the total efficiency of 93.75%. Control group were cured 10 cases,significant progress in five cases,improved in 7 cases,10 cases,the total efficiency 68.75%. Treatment group than the control group(P<0.05)[.Conclusion] Yinxingdamo injection combined treatment of acute cerebral infarction Kelinao effect is remarkable,worthy of promotion.